Bilateral Meetings
- Wednesday 10:40 h – 13:00 h
- Wednesday 14:00 h – 18:00 h
DescriptionExogenus Therapeutics (Exo-T) is a biotechnology company dedicated to pre-clinical and clinical development of advanced therapies for skin diseases. Exo-T envisage becoming a company of reference for the use of exosomes as a treatment tool for skin lesions, including wound healing. The company is presently developing its first product, Exo-Wound, which is derived from Umbilical Cord Blood for the treatment of chronic wounds, which affect millions of people worldwide.
Organization Type
Company
Areas of Activities
Other
PARTNERS WANTED: BIOBANKS & GMP-COMPLIANT PRODUCTION
We are looking for biobanks working with Umbilical Cord Blood for research & development based in Europe or USA. We are also looking for GMP production contractors with experience in cell therapy.
Cooperation Requested
- Manufacturing agreement
Health - Life Sciences Investment
We are looking for investors for the clinical development phase of our product.
Cooperation Requested
- Investment/Financing
Wound care licensing opportunity
We are looking for pharma companies commercializing Wound Care products for future out licensing of our product or technology.
Cooperation Offered
- License agreement
Wound healing Animal Testing
We are looking for partners to develop experiments in animal models such as wound healing efficacy tests and GLP toxicology.
Cooperation Requested
- Research co-operation